# Safety and Tolerability of Kiddi® Pharmaton Fizz Effervescent Tablets in Children

> **NCT02184325** · PHASE2 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 96 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Kiddi® Pharmaton Fizz, effervescent tablets
- **DRUG:** Kiddi® Pharmaton Fizz, effervescent tablets: marketed formula
- **DRUG:** Comparator product

## Key facts

- **NCT ID:** NCT02184325
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-11
- **Primary completion:** 2000-02
- **Final completion:** —
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2014-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02184325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02184325, "Safety and Tolerability of Kiddi® Pharmaton Fizz Effervescent Tablets in Children". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02184325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*